TAT (YGRKKRRQRRR) is derived from the transactivator of transcription (TAT) of human immunodeficiency virus-1 (HIV-1) and is a cell-penetrating peptide. TAT can increase the yields and the solubility of heterologous proteins.
CAT No: GR1204
CAS No:191936-91-1
Synonyms/Alias:191936-91-1;HIV-1 Tat Protein (47-57);HIV-1 Tat Protein Peptide;H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-OH;YGRKKRRQRRR;tat peptide (47-57);Tat protein (47-57);HIV-1;SCHEMBL5965085;CHEMBL4203498;DTXSID20648680;PUBCHEM_25080835;TAT 47-57;AKOS040764101;TS-10468;G78781;191936-91-1, HIV-1 Tat protein (47-57) ; tat peptide (47-57), Human immunodeficiency virus 1 ; Tat protein (47-57), HIV-1;
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.